Record

Hard work and happy accidents: why do so many of us prefer ‘difficult’ analogue technology?

Retrieved on: 
Thursday, April 18, 2024

Up two flights of stairs, the music machinery on offer includes brands such as Moog and Buchla, as well as modern euro-racks.

Key Points: 
  • Up two flights of stairs, the music machinery on offer includes brands such as Moog and Buchla, as well as modern euro-racks.
  • (From Michael’s fieldnotes)
    I finally locate the legendary Schneiders Buero, a shop selling analogue synthesizers in Berlin’s Kotti neighbourhood.
  • Up two flights of stairs, the music machinery on offer includes brands such as Moog and Buchla, as well as modern euro-racks.
  • (From Michael’s fieldnotes) As academics who rarely go a day without playing or making music, we have spent the past decade examining the extraordinary revival of analogue technology.
  • This means there are now more analogue options available than at any time since the 1970s, the heyday of the modular format.

The appeal of the slow

  • So we dived in.
  • Eventually, these forays became our formal research project, which has included visiting record fairs and conventions around the world, going on photowalks and attending listening evenings, and meeting an array of diehard analogue communities both on and off line.
  • The team is working with academics from different backgrounds who have been engaged in projects aimed at tackling societal and scientific challenges.
  • And we expect interest in such experiences to rise exponentially in coming years.
  • Recognising our existential need to occasionally slow down can be the basis for winning consumer strategies.
  • Recognising our existential need to occasionally slow down can be the basis for winning consumer strategies.

Saved from demolition

  • Rather than nostalgia, they are turning to film because of its aesthetic values and a greater sense of creative control over their photos.
  • In response, venerable brands including Kodak, Polaroid and Leica have re-emerged – in some cases, almost from the dead.
  • We literally saved it from demolition at the very last second in 2008.
  • We literally saved it from demolition at the very last second in 2008.
  • He said luxury brands such as Gucci are particularly keen on using film photography as this gives their promotional material a different look.

Work, effort, meaning

  • When it was conceded that digital probably was better for wildlife photography, James cut in:
    That’s to miss the point!
  • The sound might be better but you miss seeing the work that went into the performance, the effort of the players and their crew.
  • Work, effort, meaning – these ideas are all interconnected for users and consumers of analogue technology.
  • However, when asked to compare the two, they talk about the greater weight and meaning they give to their analogue experiences.
  • I think it is the quality of the human voice; it does feel more like someone’s speaking to me.
  • And part of what makes this possible is the process of analogue recording, in which all the sounds being made, including the unscripted noise of the recording process itself, are captured in the final track.
  • To facilitate this sound, some musicians have even started setting up their own pressing plants, such as Jack White’s Third Man Pressing in Detroit.

The joy of happy accidents

  • Half of what you do trying to make music is like a happy accident that ends up sounding better than what you intended.
  • When we started, we didn’t have that technology, so we made mistakes and some of them were happy accidents, resulting in iconic tracks.
  • When we started, we didn’t have that technology, so we made mistakes and some of them were happy accidents, resulting in iconic tracks.
  • It’s these happy accidents that we love.
  • It’s these happy accidents that we love.
  • For example, the opening bass part of Cannonball, the 1993 song by US Indie band the Breeders, accidentally starts in a different key.
  • Bass player Josephine Wiggs began playing the riff one step down, then fixed it when the drums came in.

Digital technology is de-skilling us

  • Over the decade or so of our research, explanations for the analogue revival have shifted from nostalgia, to the desire for something physical in a digital age, to the sense that analogue technology is creatively preferable.
  • Is digital technology de-skilling consumers, leading to a sense of alienation?
  • Using analogue technology is another way consumers can feed this desire to re-skill.
  • Rob told us how his love of music had turned sour with the “sheer ease” of digital, starting with CDs and the MP3 player – and how vinyl had reinvigorated him.
  • For him, the problem came when listening on digital devices without the “sides” of vinyl albums, and then on music streaming platforms whose digital algorithms preference popular tracks.

‘This song sucks’

  • These are the people who want to stretch and break the rules and trigger the happy accidents that create something altogether new.
  • For example, photographers who seek more creative expressions by pre-soaking or “souping” their camera film in lemon juice, coffee, beer, or even burning it.
  • And among this group, connecting digital and analogue technology is also common – combining two completely different systems to generate even more possibilities.
  • Film director Denis Villeneuve’s first instalment of Dune (2021) was initially shot on digital, then transferred to film, before being re-digitised.
  • By combining the two, Villeneuve got a film that, in his words, has a “more timeless, painterly feel”.


For you: more from our Insights series:
How music heals us, even when it’s sad – by a neuroscientist leading a new study of musical therapy

The artist formerly known as Camille – Prince’s lost album ‘comes out’

Beatrix Potter’s famous tales are rooted in stories told by enslaved Africans – but she was very quiet about their origins

To hear about new Insights articles, join the hundreds of thousands of people who value The Conversation’s evidence-based news. Subscribe to our newsletter.
The authors do not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and have disclosed no relevant affiliations beyond their academic appointment.

Many suicides are related to gambling. How can we tackle this problem?

Retrieved on: 
Thursday, April 18, 2024

Whether you’re watching TV, attending a footy game, or eating a meal at your local pub, gambling is hard to escape. Although the rise of gambling is not unique to Australia, it has become normalised as a part of Australian culture. While for some, gambling might be a source of entertainment, for others, it can lead to significant harms.Gambling and mental illnessIn many cases, harms associated with gambling lead to poor mental health.

Key Points: 


Whether you’re watching TV, attending a footy game, or eating a meal at your local pub, gambling is hard to escape. Although the rise of gambling is not unique to Australia, it has become normalised as a part of Australian culture. While for some, gambling might be a source of entertainment, for others, it can lead to significant harms.

Gambling and mental illness

  • In many cases, harms associated with gambling lead to poor mental health.
  • But people experiencing mental illness are also at greater risk of experiencing gambling problems.
  • A person might not have a diagnosable gambling disorder, however they still may face problems in their life as a result of gambling.

Gambling and suicide

  • Research from different countries has shown that among people receiving treatment for problem gambling, between 22% and 81% have thought about suicide, and 7% to 30% have made an attempt.
  • Some 44% of Australian veterans experiencing gambling problems have thought about suicide, while almost 20% have made a suicide plan or attempt.
  • Gambling-related suicides were more likely to affect males (83%) compared to total suicide deaths in Victoria over the same period (75%).
  • This is because, unlike for drugs and alcohol, at present there’s no systematic way gambling is captured as a contributing factor in suicide deaths.

Gambling is inherently risky

  • Evidence shows pokies alone are responsible for more than half of all gambling problems in Australia.
  • Casino table games are equally risky, but in the general population they contribute much less to problem gambling because fewer people play them.

What can we do?

  • She suggested health professionals could make it part of their routine practice to ask simple questions like “in the past 12 months, have you ever felt that you had a problem with gambling?”.
  • Or, “has anyone commented that you might have a problem with gambling?”.
  • In June 2023, a cross-party committee presented a report with 31 recommendations to reduce harms from online gambling in Australia.
  • Read more:
    Celebrities, influencers, loopholes: online gambling advertising faces an uncertain future in Australia

Advice for people who gamble

  • For people who do choose to gamble, it’s important to be aware of the risks.
  • If you choose to gamble, set limits on the amount of money you’re willing to loose, or the amount of time you will spend gambling.


gamble no more than 2% of your take-home pay
gamble no more than once a week
take part in no more than two different types of gambling.
If you notice you’re thinking about gambling more and more, or that it’s causing problems in any part of your life, seeking help early is key. Speak to your GP about how you can get some extra support, or visit Gambling Help Online. If this article has raised issues for you, or if you’re concerned about someone you know, call Lifeline on 13 11 14.
Anastasia Hronis does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

Draft guideline on good agricultural and collection practice (GACP) for starting materials of herbal origin - Revision 1

Retrieved on: 
Thursday, April 18, 2024

REFERENCES ....................................................................................................................................... 14

Key Points: 
    • REFERENCES ....................................................................................................................................... 14

      29

      Guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin
      EMA/HMPC/246816/2005

      Page 3/14

      30

      EXECUTIVE SUMMARY

      31
      32
      33
      34
      35
      36

      This guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin

      37

      1.

    • Due to the inherent
      complexity of medicinal plants and herbal substances the quality of these starting materials requires an
      adequate quality assurance system for the collection and/or cultivation, harvest, and primary
      processing.
    • (either outdoor, indoor or in greenhouses) should be carefully considered, since each of the mentioned
      types could have several problems and advantages.
    • The used cultivation method may be dependent on
      the final application of the herbal medicinal product.
    • primary processing of herbal substances that are used for the preparation of herbal medicinal products.
    • medicinal plants and herbal substances, ensuring that they are handled appropriately throughout all
      stages of cultivation, collection, processing and storage.
    • their preparations are exposed to a large number of environmental contaminants of both biotic and
      abiotic origin.
    • to existing wildlife habitats and must adhere to CITES (Convention on International Trade in
      Endangered species of Wild Fauna and Flora).
    • https://health.ec.europa.eu/document/download/bd537ccf-9271-4230-bca1-2d...
      4 https://health.ec.europa.eu/document/download/fd318dd6-2404-4e67-82b0232...
      3

      Guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin
      EMA/HMPC/246816/2005

      Page 5/14

      104

      4.

    • Guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin
      EMA/HMPC/246816/2005

      Page 6/14

      147
      148
      149

      8.

    • Guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin
      EMA/HMPC/246816/2005

      Page 7/14

      185

      7.

    • Where possible, stable varieties and cultivars naturally
      Guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin
      EMA/HMPC/246816/2005

      Page 8/14

      227
      228

      resistant or tolerant to disease should preferably be used.

    • Guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin
      EMA/HMPC/246816/2005

      Page 9/14

      268
      269
      270
      271
      272
      273

      The application should be carried out only by qualified staff using approved equipment.

    • The following should be noted:

      Guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin
      EMA/HMPC/246816/2005

      Page 10/14

      309
      310

      ?

      311
      312
      313

      ?

      314
      315
      316
      317

      ?

      318
      319
      320

      ?

      321
      322

      ?

      323
      324
      325

      ?

      326
      327
      328

      ?

      Damaged plants or plant parts need to be excluded or limited in accordance with a specific
      pharmacopoeia monograph, where relevant.

    • Guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin
      EMA/HMPC/246816/2005

      Page 11/14

      347
      348

      directly to the sun (except in cases where there is a specific need) and must be protected from
      rainfall, insect infestation, etc.

    • The label must be clear, permanently fixed and made from

      6

      Reflection paper on the use of fumigants (EMEA/HMPC/125562/2006)

      Guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin
      EMA/HMPC/246816/2005

      Page 12/14

      386
      387

      non-toxic material.

    • Certain exudates that have not been subjected to a specific treatment are

      Guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin
      EMA/HMPC/246816/2005

      Page 13/14

      425
      426
      427

      also considered to be herbal substances.

    • European Pharmacopoeia General Monograph ?HERBAL DRUGS? 07/2017:1433

      Are obtained by subjecting herbal substances to treatments such as
      extraction, distillation, expression, fractionation, purification, concentration
      or fermentation.

Draft revised Heads of Medicines Agency / European Medicines Agency guidance document on the identification of personal data and commercially confidential information within the structure of the marketing authorisation application dossier

Retrieved on: 
Thursday, April 18, 2024
Steps, Union, Patient, CTD, Syndrome, CCI, Local, Disclosure, Toxicity, Process validation, MAH, Clinical trial, IP, RMP, Pharmacovigilance, Cell, Legislation, Annex, Trial of the century, Escherichia coli, Safety, Pediatrics, INTRODUCTION, Documentation, Prevalence, Vital signs, Tablet, Design, Transparency, Conclusion, Pip, Analysis, European Parliament, INN, Record, Quality, Generic, Biology, CMO, Genotoxicity, Composition, CTIS, Uncontrolled, Health care, European Medicines Agency, Prejudice, Committee, Policy, HCP, Animal, Characterization, Cell bank, Fertility, IRB, CMOS, Risk management, Private law, European Pharmacopoeia, Telephone, Research, Good, Data Protection Directive, Ampere-hour, IEC, QP, Human, Personal data, Labelling, Bibliography, Figure, MAA, R4, Institutional review board, Elucidation, Marketing, M4, ChromeOS, Contract research organization, Mental, Impairment, Toxicokinetics, NCA, Independent, Metabolite, Drug, Risk, Metabolism, GMO, Organ, EMA, Common Technical Document, General Data Protection Regulation, Confidentiality, PPD, PI, Language, DRUG, Privacy, Result, Claimed, Medication, Comparison, Ethics, Drive, PD, Narrative, EEA, Developmental toxicity, Saccharomyces cerevisiae, Pharmacopoeia, PIP, MCB, HMA, Physical chemistry, Midol, Particle size, Council, GCP, European Economic Area, Draft, Fermentation, Overview, Justification, Control, Dicarboxylic acid, Pharmacology, WCB, Expert, Immunogenicity, Data, Study, Publication, European, ICH, Element, Analytical procedures (finance auditing), Name, Common, Guideline, Exceptional circumstances, ID, Liver, Chin Na, Toxicology, Protein primary structure, Immunosuppressive drug, Vaccine

See websites for contact details

Key Points: 
    • See websites for contact details
      Heads of Medicines Agencies www.hma.eu
      European Medicines Agency www.ema.europa.eu

      11

      Table of contents

      12

      Abbreviations .............................................................................................. 3

      13

      Definitions ................................................................................................... 4

      14

      1.

    • redaction, masking,

      68

      hiding) in such a manner that the recipient can no longer attribute the resulting information to a data

      69

      subject and make it identifiable.

    • 81

      Contract Manufacturing Organisation (CMO): shall mean an arrangement under which a

      82

      manufacturer provides upstream manufacturing services under contract on behalf of third-party

      83

      pharmaceutical companies.

    • 94

      Protected Personal Data (PPD): shall mean any personal data which should be protected from

      95

      disclosure.

    • ?Finalised? shall mean that the marketing

      102

      authorisation (MA) has been granted or refused or that the MAA has been withdrawn.

    • The application of the general principles laid down in this guidance is without prejudice to

      106

      national rules on transparency.

    • The guidance should be read in conjunction with the relevant applicable

      107

      legislation and case law on transparency and data protection.

    • 117

      This guidance document is intended to apply to information/documents on medicinal products for

      118

      human use, for which the procedure has been finalised under the national, mutual recognition,

      119

      decentralised and centralised procedures.

    • Third

      124

      parties shall be informed or consulted as needed depending on respective national and European legal

      125

      frameworks.

    • 140

      In the following sections, the agreed principles on PD and CCI are presented, including guidance on

      141

      whether such information can be disclosed.

    • EMA/131365/2024

      Page 5/50

      142

      Any information identified as PD or CCI must be subject to a preliminary review by the EMA/NCA prior

      143

      to the possible disclosure of the information/documents.

    • Principles on the protection of personal data (PD)

      145

      The protection of PD is enshrined in EU legislation; it is a fundamental right of EU citizens.

    • In

      146

      compliance with the applicable European/national legislation, PD should be anonymised in order to

      147

      avoid the disclosure of the document undermining the privacy and integrity of any individual.

    • EMA/NCA applies a risk-based approach to assess which PD elements are to be

      152

      removed from the information/documents in order to limit the risk of re-identification.

    • are included in the MAA dossier because they have a legally

      164

      defined role or responsibility and it is in the public interest to disclose this data.

    • 168

      Applicants are advised that non-essential information (e.g., personal address, personal phone number)

      169

      should not be included in the MAA dossier.

    • The

      183

      confidentiality of records that could identify subjects should be protected, respecting the privacy and

      184

      confidentiality rules in accordance with the applicable regulatory requirement(s).

    • 185

      The applicant remains responsible for compliance with the relevant legislation in cases where such data

      186

      is inadvertently included in the MAA dossier.

    • 188

      EMA/NCA applies a risk-based approach to assess which personal data elements need to be removed

      189

      from the information/documents in order to limit the risk of re-identification.

    • 194

      EMA/NCA applies a risk-based approach to assess which personal data elements need to be removed

      195

      from the information/documents in order to limit the risk of re-identification.

    • 205

      Any proposal to consider information as commercially confidential should be properly justified by the

      206

      owner of the information.

    • In this respect, any reference(s) to the risk of that interest being

      209

      undermined should be foreseeable and not purely hypothetical.

    • 210

      Information that is already in the public domain is not considered to be commercially confidential.

    • Information on the Quality and Manufacturing of medicines

      226

      A general principle regarding quality and manufacturing information is that detailed information could

      227

      be considered commercially confidential but general information should be disclosed.

    • 234

      In general, and if not in the public domain, the names of manufacturers or suppliers of the active

      235

      substance or the excipients are considered commercially confidential.

    • 248

      A general description of the type of test methods used and the appropriateness of the specification is

      249

      not commercially confidential.

    • General information on the fermentation and purification process

      259

      is not commercially confidential, although details including operating parameters and specific material

      260

      requirements are commercially confidential.

    • 273

      A general description of the type of test methods used and the appropriateness of the specification is

      274

      not commercially confidential.

    • In general, the data included in clinical trial study reports is considered to be data that can be

      283

      disclosed once PD has been anonymised.

    • 338

      In each module, a non-exhaustive list of information that may be considered protected personal data (PPD) or commercially confidential information

      332
      333

      339

      (CCI) is included.

    • ?

      Direct contact details such as telephone

      Therefore, please refer to the appropriate sub-

      number, fax number, email, postal address,

      modules hereafter for guidance.

    • ?

      Information that may reveal strategic
      (contractual) agreements

      ?

      Any quality information on the clinical batches

      principal investigator

      that might be included here (such as e.g.

    • ?

      Information that may reveal strategic
      (contractual) agreements

      principal investigator

      Study Reports
      5.3.3.3

      as the evaluation of new formulation, innovative

      number, fax number, email, postal

      Paediatric Development Plan (PIP), etc.

    • This may include taking into

      More Than One Study
      5.3.5.4

      Other Clinical Study Reports

      5.3.6

      Reports of Post-Marketing
      Experience

      5.3.7

      Direct identifiers such as name,
      signature, contact details, etc.

Draft guideline on good agricultural and collection practice (GACP) for starting materials of herbal origin - Revision 1

Retrieved on: 
Thursday, April 18, 2024

REFERENCES ....................................................................................................................................... 14

Key Points: 
    • REFERENCES ....................................................................................................................................... 14

      29

      Guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin
      EMA/HMPC/246816/2005

      Page 3/14

      30

      EXECUTIVE SUMMARY

      31
      32
      33
      34
      35
      36

      This guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin

      37

      1.

    • Due to the inherent
      complexity of medicinal plants and herbal substances the quality of these starting materials requires an
      adequate quality assurance system for the collection and/or cultivation, harvest, and primary
      processing.
    • (either outdoor, indoor or in greenhouses) should be carefully considered, since each of the mentioned
      types could have several problems and advantages.
    • The used cultivation method may be dependent on
      the final application of the herbal medicinal product.
    • primary processing of herbal substances that are used for the preparation of herbal medicinal products.
    • medicinal plants and herbal substances, ensuring that they are handled appropriately throughout all
      stages of cultivation, collection, processing and storage.
    • their preparations are exposed to a large number of environmental contaminants of both biotic and
      abiotic origin.
    • to existing wildlife habitats and must adhere to CITES (Convention on International Trade in
      Endangered species of Wild Fauna and Flora).
    • https://health.ec.europa.eu/document/download/bd537ccf-9271-4230-bca1-2d...
      4 https://health.ec.europa.eu/document/download/fd318dd6-2404-4e67-82b0232...
      3

      Guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin
      EMA/HMPC/246816/2005

      Page 5/14

      104

      4.

    • Guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin
      EMA/HMPC/246816/2005

      Page 6/14

      147
      148
      149

      8.

    • Guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin
      EMA/HMPC/246816/2005

      Page 7/14

      185

      7.

    • Where possible, stable varieties and cultivars naturally
      Guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin
      EMA/HMPC/246816/2005

      Page 8/14

      227
      228

      resistant or tolerant to disease should preferably be used.

    • Guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin
      EMA/HMPC/246816/2005

      Page 9/14

      268
      269
      270
      271
      272
      273

      The application should be carried out only by qualified staff using approved equipment.

    • The following should be noted:

      Guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin
      EMA/HMPC/246816/2005

      Page 10/14

      309
      310

      ?

      311
      312
      313

      ?

      314
      315
      316
      317

      ?

      318
      319
      320

      ?

      321
      322

      ?

      323
      324
      325

      ?

      326
      327
      328

      ?

      Damaged plants or plant parts need to be excluded or limited in accordance with a specific
      pharmacopoeia monograph, where relevant.

    • Guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin
      EMA/HMPC/246816/2005

      Page 11/14

      347
      348

      directly to the sun (except in cases where there is a specific need) and must be protected from
      rainfall, insect infestation, etc.

    • The label must be clear, permanently fixed and made from

      6

      Reflection paper on the use of fumigants (EMEA/HMPC/125562/2006)

      Guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin
      EMA/HMPC/246816/2005

      Page 12/14

      386
      387

      non-toxic material.

    • Certain exudates that have not been subjected to a specific treatment are

      Guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin
      EMA/HMPC/246816/2005

      Page 13/14

      425
      426
      427

      also considered to be herbal substances.

    • European Pharmacopoeia General Monograph ?HERBAL DRUGS? 07/2017:1433

      Are obtained by subjecting herbal substances to treatments such as
      extraction, distillation, expression, fractionation, purification, concentration
      or fermentation.

How “location, location, location” can lead to “enforcement, enforcement, enforcement”

Retrieved on: 
Friday, April 12, 2024

How “location, location, location” can lead to “enforcement, enforcement, enforcement”

Key Points: 

How “location, location, location” can lead to “enforcement, enforcement, enforcement”

Why so few witches were executed in Wales in the middle ages

Retrieved on: 
Wednesday, April 10, 2024

While there were an estimated 500 executions in England, and between 3,000 and 4,000 killings in Scotland, only five people were hanged for witchcraft in Wales.

Key Points: 
  • While there were an estimated 500 executions in England, and between 3,000 and 4,000 killings in Scotland, only five people were hanged for witchcraft in Wales.
  • Early modern Wales was unique in its outlook on witchcraft.
  • Distinct elements of Welsh culture, including superstition and religion, halted the witch trials seen across the rest of Britain and Europe.

Accusations of witchcraft

  • We know from those trial records that suspicions and verbal accusations of witchcraft like those seen across the rest of Britain and Europe were common in Wales.
  • They also happened under similar circumstances where accusations often followed an argument, or a request for charity which was denied.
  • Their accusers were neighbours, relatives and in many cases, people with financial and personal reasons to make accusations.
  • This left juries in early modern Wales in serious doubt about how sensible witch accusations were.

Religion

  • The people of Wales were not without religion, but they preferred prayer to doctrine.
  • Generally, Welsh people could not read or understand the Bible, which was not fully translated into Welsh until the late 1500s.
  • There is evidence that many people continued to seek the aid of charmers instead of the church.
  • This sort of formal cursing was often phrased as a petitionary prayer to God, emphasising the overlap between witchcraft and religion in Wales.


Mari Ellis Dunning does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

Sunrise Wind receives federal record of decision, takes final investment decision

Retrieved on: 
Wednesday, April 10, 2024

Sunrise Wind receives federal record of decision, takes final investment decision

Key Points: 
  • Sunrise Wind receives federal record of decision, takes final investment decision
    Sunrise Wind today received its Record of Decision (RoD) from the US Department of the Interior's Bureau of Ocean Energy Management (BOEM), crossing a critical milestone in the federal environmental review process for the offshore wind project serving New York.
  • Additionally, Ørsted and Eversource today announced they have jointly taken a final investment decision on Sunrise Wind, solidifying the commitment to build the project, and will now advance with some important onshore construction activities.
  • Sunrise Wind will bring USD 700 million of investment to Suffolk County and create 800 direct jobs and thousands of indirect jobs in the state.
  • With the federal Record of Decision in hand and our final investment decision having been made, we can continue to create hundreds of local union jobs and stand up a vibrant supply chain.

Turkiye Garanti Bankasi A.S.: Information regarding the results of Ordinary General Shareholders' Meeting

Retrieved on: 
Wednesday, April 10, 2024

The meeting minutes, list of participants and the profit distribution table are attached hereto.

Key Points: 
  • The meeting minutes, list of participants and the profit distribution table are attached hereto.
  • (The meeting minutes and the profit distribution table are in Turkish and English, whereas the list of participants is in Turkish.)
  • *In contradiction between the Turkish and English versions of this public disclosure, the Turkish version shall prevail.
  • Contact Garanti BBVA Investor Relations:

EQS-News: Aumann significantly increases revenue in 2023, doubles EBITDA and achieves new record figures for order intake and liquidity

Retrieved on: 
Wednesday, April 10, 2024

Aumann significantly increases revenue in 2023, doubles EBITDA and achieves new record figures for order intake and liquidity

Key Points: 
  • Aumann significantly increases revenue in 2023, doubles EBITDA and achieves new record figures for order intake and liquidity
    The issuer is solely responsible for the content of this announcement.
  • Aumann significantly increases revenue in 2023, doubles EBITDA and achieves new record figures for order intake and liquidity
    Aumann AG ("Aumann", ISIN: DE000A2DAM03), a leading manufacturer of automation solutions for electromobility, successfully continued its profitable growth trajectory in the 2023 financial year.
  • Aumann's revenue grew dynamically by 34.5% to €289.6 million, with revenue in the E-mobility segment increasing particularly strongly by 61.2% to €229.1 million.
  • Order intake exceeded the successful previous year by 14.9% and reached a new record in the company’s history at €339.4 million.